ALNYNasdaqPharmaceutical Preparations

Alnylam Pharmaceuticals, Inc. (ALNY) earnings date, market-implied expected move, and options open interest by expiry

159.86

pre 162.45 +1.60%

Pre-market06:21 ETdelayed

Open161.19Volume3.8MMkt cap$21.4BP/E8.20EPS19.82

Day161.19 – 162.45100%52-wk156.00 – 479.792%

ALNY

Alnylam Pharmaceuticals, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Feb 11

before open · in 99 days

est.Q4 FY26

Calendar

Next report

Last report

−25.13%

vs ±11.1% implied · ×2.27

shaded = implied · ▲▼ = realized

Oct 29 '26 · confirmed

Implied vs realized

Linked news

1dBX · supplierBlackstone president calls for more equity to fund AI buildout as debt risks mount
1dNVS · customerBioArctic collaborator Novartis terminates agreement
4dSNY · supplierSanofi Q3 sales €14,444 million, business EPS €3.55; upgrades 2026 guidance

News

Largest filed tie

13F top-10 QoQ

+2.73%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

796 managers

Top fund weight

0.96%

ALNY weight · XBI

N-PORTJun 30 '26

5 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Alnylam Pharmaceuticals (ALNY) is expected to report on Feb 11 before open (estimated date).

Implied vs realized

8 reports

—≥ implied

Jan 13 '25Jan 13 '25confirmed—▲+8.53%—

Jul 31 '25Jul 31 '25confirmed—▲+15.43%—

Oct 30 '25Oct 30 '25confirmed—▼−6.65%—

Jan 12 '26Jan 12 '26confirmed—▼−6.87%—

Feb 12 '26Feb 12 '26confirmed—▼−4.28%—

Q1 FY26Apr 30 '26confirmed—▲+2.76%—

Q2 FY26Jul 30 '26confirmed—▼−28.31%—

Q3 FY26Oct 29 '26confirmed±11.1%▼−25.13%×2.27

quarterimplied−30%0+30%realized×

Q3 FY26±11.1%▼−25.13%×2.27

Q2 FY26—▼−28.31%—

Q1 FY26—▲+2.76%—

Feb '26—▼−4.28%—

Jan '26—▼−6.87%—

Oct '25—▼−6.65%—

2 older reports

Jul '25—▲+15.43%—

Jan '25—▲+8.53%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Oct 30 close

1.51OI · 4 expiries · Oct 30 closeP/C open interest · Mar 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

4,018+14%Nov 2016d1.083,706+28%1.08

2,890−15%Dec 1844d0.803,628+9%0.80

4,317−19%Jan 1572d0.2517,178+21%0.25

report · Feb 11 · before open · est.

3,107+1%Mar 19135d2,055+5%

ExpiryPutsCallsP/C

Nov 2016d4,018+14%3,706+28%1.08

Dec 1844d2,890−15%3,628+9%0.80

Jan 1572d4,317−19%17,178+21%0.25

report · Feb 11 · before open · est.

Mar 19135d3,107+1%2,055+5%1.51

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

148.64%as filednet margin · revenue +12.95% QoQ · +16.74% YoY

Revenue

$1.5B+12.95% QoQ

Gross profit

$1.1B+10.46% QoQ

75.19% margin

Operating income

$346M+49.41% QoQ

23.72% margin

Pre-tax income

$296M+66.37% QoQ

Net income

$2.2B+1217.58% QoQ

148.64% margin

Cost of revenue

$362M+21.21% QoQ

Operating expenses

$751M−1.38% QoQ

R&D $409M

SG&A $342M

Other expense

$50M

Tax benefit

$1.9B

Revenue$1.5B+12.95%

Gross profit

$1.1B+10.46%

75.19% margin

Operating income

$346M+49.41%

23.72% margin

Pre-tax income

$296M+66.37%

Net income

$2.2B+1217.58%

148.64% margin

Cost of revenue

$362M+21.21%

Operating expenses

$751M−1.38%

R&D $409M

SG&A $342M

Other expense

$50M

Tax benefit$1.9B

flow · deduction · signed % = QoQSource: SEC filings · standardized · QE Sep 30 '26 · width = $

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 06:15 ET

Intraday

Event sensitivity

PCE ×2.69· ±5.0% vs ±1.9% · 20 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±5.0%8 of 20×2.69

GDPgross domestic product±4.2%8 of 20×2.26

FOMCrate decision±1.9%12 of 24×1.00

PPIproducer prices±1.7%4 of 11×0.92

CPROFcorporate profits±1.6%4 of 12×0.84

CPIconsumer prices±1.2%7 of 11×0.64

NFPjobs report±1.2%4 of 10×0.63

Bar = avg |move| to ±6% · tick = ±1.9% avg day · ×base = |move| ÷ ±1.9% · min 6 releases

Earnings history

EPS 15.72 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Oct 29 '26 · confirmed	15.72	—
Q2 FY26	Jul 30 '26 · confirmed	1.21	—
Q1 FY26	Apr 30 '26 · confirmed	1.51	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod